Kansai Electric Power Hospital

Osaka, Osaka 553-0003

0 studies enrolling now · 2 studies all time

What they study most

ALS, Dyslipidemia, Type2 Diabetes

Studies at this site

• Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early